Human Coagulation Factor VIII Industry Research Report 2024
Summary
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, the global Human Coagulation Factor VIII market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Coagulation Factor VIII by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, the global Human Coagulation Factor VIII market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.
The report will help the Human Coagulation Factor VIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor VIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Coagulation Factor VIII by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Coagulation Factor VIII Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Coagulation Factor VIII Sales (2019-2030)
2.2.3 Global Human Coagulation Factor VIII Market Average Price (2019-2030)
2.3 Human Coagulation Factor VIII by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Recombinant Factor VIII
2.3.3 Plasma-derived Factor VIII
2.4 Human Coagulation Factor VIII by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hemophilia A
2.4.3 Spontanous / Trauma
2.4.4 Surgical
2.4.5 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Human Coagulation Factor VIII Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Coagulation Factor VIII Sales (K Bottles) of Manufacturers (2019-2024)
3.3 Global Human Coagulation Factor VIII Revenue of Manufacturers (2019-2024)
3.4 Global Human Coagulation Factor VIII Average Price by Manufacturers (2019-2024)
3.5 Global Human Coagulation Factor VIII Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Coagulation Factor VIII, Product Type & Application
3.8 Global Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
3.9 Global Human Coagulation Factor VIII Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Shire (Baxter)
4.1.1 Shire (Baxter) Company Information
4.1.2 Shire (Baxter) Business Overview
4.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
4.1.5 Shire (Baxter) Recent Developments
4.2 Bayer
4.2.1 Bayer Company Information
4.2.2 Bayer Business Overview
4.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
4.2.5 Bayer Recent Developments
4.3 CSL
4.3.1 CSL Company Information
4.3.2 CSL Business Overview
4.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.3.4 CSL Human Coagulation Factor VIII Product Portfolio
4.3.5 CSL Recent Developments
4.4 Pfizer
4.4.1 Pfizer Company Information
4.4.2 Pfizer Business Overview
4.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
4.4.5 Pfizer Recent Developments
4.5 Grifols
4.5.1 Grifols Company Information
4.5.2 Grifols Business Overview
4.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
4.5.5 Grifols Recent Developments
4.6 Biogen
4.6.1 Biogen Company Information
4.6.2 Biogen Business Overview
4.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
4.6.5 Biogen Recent Developments
4.7 Octapharma
4.7.1 Octapharma Company Information
4.7.2 Octapharma Business Overview
4.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
4.7.5 Octapharma Recent Developments
4.8 NovoNordisk
4.8.1 NovoNordisk Company Information
4.8.2 NovoNordisk Business Overview
4.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
4.8.5 NovoNordisk Recent Developments
4.9 Greencross
4.9.1 Greencross Company Information
4.9.2 Greencross Business Overview
4.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
4.9.5 Greencross Recent Developments
4.10 Kedrion
4.10.1 Kedrion Company Information
4.10.2 Kedrion Business Overview
4.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
4.10.5 Kedrion Recent Developments
4.11 BPL
4.11.1 BPL Company Information
4.11.2 BPL Business Overview
4.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.11.4 BPL Human Coagulation Factor VIII Product Portfolio
4.11.5 BPL Recent Developments
4.12 Hualan Bio
4.12.1 Hualan Bio Company Information
4.12.2 Hualan Bio Business Overview
4.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
4.12.5 Hualan Bio Recent Developments
4.13 RAAS
4.13.1 RAAS Company Information
4.13.2 RAAS Business Overview
4.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
4.13.5 RAAS Recent Developments
5 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET SCENARIO BY REGION
5.1 Global Human Coagulation Factor VIII Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Coagulation Factor VIII Sales by Region: 2019-2030
5.2.1 Global Human Coagulation Factor VIII Sales by Region: 2019-2024
5.2.2 Global Human Coagulation Factor VIII Sales by Region: 2025-2030
5.3 Global Human Coagulation Factor VIII Revenue by Region: 2019-2030
5.3.1 Global Human Coagulation Factor VIII Revenue by Region: 2019-2024
5.3.2 Global Human Coagulation Factor VIII Revenue by Region: 2025-2030
5.4 North America Human Coagulation Factor VIII Market Facts & Figures by Country
5.4.1 North America Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Coagulation Factor VIII Sales by Country (2019-2030)
5.4.3 North America Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
5.5.1 Europe Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Coagulation Factor VIII Sales by Country (2019-2030)
5.5.3 Europe Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Coagulation Factor VIII Market Facts & Figures by Country
5.6.1 Asia Pacific Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Coagulation Factor VIII Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
5.7.1 Latin America Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Coagulation Factor VIII Sales by Country (2019-2030)
5.7.3 Latin America Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030)
6.1.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030) & (K Bottles)
6.1.2 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
6.2 Global Human Coagulation Factor VIII Revenue by Type (2019-2030)
6.2.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
6.3 Global Human Coagulation Factor VIII Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030)
7.1.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030) & (K Bottles)
7.1.2 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
7.2 Global Human Coagulation Factor VIII Revenue by Application (2019-2030)
7.2.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
7.3 Global Human Coagulation Factor VIII Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Human Coagulation Factor VIII Value Chain Analysis
8.1.1 Human Coagulation Factor VIII Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Coagulation Factor VIII Production Mode & Process
8.2 Human Coagulation Factor VIII Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Coagulation Factor VIII Distributors
8.2.3 Human Coagulation Factor VIII Customers
9 GLOBAL HUMAN COAGULATION FACTOR VIII ANALYZING MARKET DYNAMICS
9.1 Human Coagulation Factor VIII Industry Trends
9.2 Human Coagulation Factor VIII Industry Drivers
9.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
9.4 Human Coagulation Factor VIII Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Coagulation Factor VIII Market Size (2019-2030) & (US$ Million)
2.2.2 Global Human Coagulation Factor VIII Sales (2019-2030)
2.2.3 Global Human Coagulation Factor VIII Market Average Price (2019-2030)
2.3 Human Coagulation Factor VIII by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Recombinant Factor VIII
2.3.3 Plasma-derived Factor VIII
2.4 Human Coagulation Factor VIII by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hemophilia A
2.4.3 Spontanous / Trauma
2.4.4 Surgical
2.4.5 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Human Coagulation Factor VIII Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Human Coagulation Factor VIII Sales (K Bottles) of Manufacturers (2019-2024)
3.3 Global Human Coagulation Factor VIII Revenue of Manufacturers (2019-2024)
3.4 Global Human Coagulation Factor VIII Average Price by Manufacturers (2019-2024)
3.5 Global Human Coagulation Factor VIII Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Coagulation Factor VIII, Product Type & Application
3.8 Global Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
3.9 Global Human Coagulation Factor VIII Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Shire (Baxter)
4.1.1 Shire (Baxter) Company Information
4.1.2 Shire (Baxter) Business Overview
4.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
4.1.5 Shire (Baxter) Recent Developments
4.2 Bayer
4.2.1 Bayer Company Information
4.2.2 Bayer Business Overview
4.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
4.2.5 Bayer Recent Developments
4.3 CSL
4.3.1 CSL Company Information
4.3.2 CSL Business Overview
4.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.3.4 CSL Human Coagulation Factor VIII Product Portfolio
4.3.5 CSL Recent Developments
4.4 Pfizer
4.4.1 Pfizer Company Information
4.4.2 Pfizer Business Overview
4.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
4.4.5 Pfizer Recent Developments
4.5 Grifols
4.5.1 Grifols Company Information
4.5.2 Grifols Business Overview
4.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
4.5.5 Grifols Recent Developments
4.6 Biogen
4.6.1 Biogen Company Information
4.6.2 Biogen Business Overview
4.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
4.6.5 Biogen Recent Developments
4.7 Octapharma
4.7.1 Octapharma Company Information
4.7.2 Octapharma Business Overview
4.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
4.7.5 Octapharma Recent Developments
4.8 NovoNordisk
4.8.1 NovoNordisk Company Information
4.8.2 NovoNordisk Business Overview
4.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
4.8.5 NovoNordisk Recent Developments
4.9 Greencross
4.9.1 Greencross Company Information
4.9.2 Greencross Business Overview
4.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
4.9.5 Greencross Recent Developments
4.10 Kedrion
4.10.1 Kedrion Company Information
4.10.2 Kedrion Business Overview
4.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
4.10.5 Kedrion Recent Developments
4.11 BPL
4.11.1 BPL Company Information
4.11.2 BPL Business Overview
4.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.11.4 BPL Human Coagulation Factor VIII Product Portfolio
4.11.5 BPL Recent Developments
4.12 Hualan Bio
4.12.1 Hualan Bio Company Information
4.12.2 Hualan Bio Business Overview
4.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
4.12.5 Hualan Bio Recent Developments
4.13 RAAS
4.13.1 RAAS Company Information
4.13.2 RAAS Business Overview
4.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)
4.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
4.13.5 RAAS Recent Developments
5 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET SCENARIO BY REGION
5.1 Global Human Coagulation Factor VIII Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Coagulation Factor VIII Sales by Region: 2019-2030
5.2.1 Global Human Coagulation Factor VIII Sales by Region: 2019-2024
5.2.2 Global Human Coagulation Factor VIII Sales by Region: 2025-2030
5.3 Global Human Coagulation Factor VIII Revenue by Region: 2019-2030
5.3.1 Global Human Coagulation Factor VIII Revenue by Region: 2019-2024
5.3.2 Global Human Coagulation Factor VIII Revenue by Region: 2025-2030
5.4 North America Human Coagulation Factor VIII Market Facts & Figures by Country
5.4.1 North America Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Human Coagulation Factor VIII Sales by Country (2019-2030)
5.4.3 North America Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Human Coagulation Factor VIII Market Facts & Figures by Country
5.5.1 Europe Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Human Coagulation Factor VIII Sales by Country (2019-2030)
5.5.3 Europe Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Human Coagulation Factor VIII Market Facts & Figures by Country
5.6.1 Asia Pacific Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Human Coagulation Factor VIII Sales by Country (2019-2030)
5.6.3 Asia Pacific Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Human Coagulation Factor VIII Market Facts & Figures by Country
5.7.1 Latin America Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Human Coagulation Factor VIII Sales by Country (2019-2030)
5.7.3 Latin America Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Coagulation Factor VIII Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2019-2030)
5.8.3 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030)
6.1.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030) & (K Bottles)
6.1.2 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
6.2 Global Human Coagulation Factor VIII Revenue by Type (2019-2030)
6.2.1 Global Human Coagulation Factor VIII Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
6.3 Global Human Coagulation Factor VIII Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030)
7.1.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030) & (K Bottles)
7.1.2 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
7.2 Global Human Coagulation Factor VIII Revenue by Application (2019-2030)
7.2.1 Global Human Coagulation Factor VIII Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
7.3 Global Human Coagulation Factor VIII Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Human Coagulation Factor VIII Value Chain Analysis
8.1.1 Human Coagulation Factor VIII Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Coagulation Factor VIII Production Mode & Process
8.2 Human Coagulation Factor VIII Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Coagulation Factor VIII Distributors
8.2.3 Human Coagulation Factor VIII Customers
9 GLOBAL HUMAN COAGULATION FACTOR VIII ANALYZING MARKET DYNAMICS
9.1 Human Coagulation Factor VIII Industry Trends
9.2 Human Coagulation Factor VIII Industry Drivers
9.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
9.4 Human Coagulation Factor VIII Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Human Coagulation Factor VIII Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Human Coagulation Factor VIII Sales (K Bottles) of Manufacturers (2018-2023)
Table 7. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Human Coagulation Factor VIII Revenue of Manufacturers (2018-2023)
Table 9. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Human Coagulation Factor VIII Average Price (USD/Bottle) of Manufacturers (2018-2023)
Table 11. Global Human Coagulation Factor VIII Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Human Coagulation Factor VIII, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Shire (Baxter) Company Information
Table 17. Shire (Baxter) Business Overview
Table 18. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 19. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 20. Shire (Baxter) Recent Developments
Table 21. Bayer Company Information
Table 22. Bayer Business Overview
Table 23. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 24. Bayer Human Coagulation Factor VIII Product Portfolio
Table 25. Bayer Recent Developments
Table 26. CSL Company Information
Table 27. CSL Business Overview
Table 28. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 29. CSL Human Coagulation Factor VIII Product Portfolio
Table 30. CSL Recent Developments
Table 31. Pfizer Company Information
Table 32. Pfizer Business Overview
Table 33. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 34. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 35. Pfizer Recent Developments
Table 36. Grifols Company Information
Table 37. Grifols Business Overview
Table 38. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 39. Grifols Human Coagulation Factor VIII Product Portfolio
Table 40. Grifols Recent Developments
Table 41. Biogen Company Information
Table 42. Biogen Business Overview
Table 43. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 44. Biogen Human Coagulation Factor VIII Product Portfolio
Table 45. Biogen Recent Developments
Table 46. Octapharma Company Information
Table 47. Octapharma Business Overview
Table 48. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 49. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 50. Octapharma Recent Developments
Table 51. NovoNordisk Company Information
Table 52. NovoNordisk Business Overview
Table 53. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 54. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 55. NovoNordisk Recent Developments
Table 56. Greencross Company Information
Table 57. Greencross Business Overview
Table 58. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 59. Greencross Human Coagulation Factor VIII Product Portfolio
Table 60. Greencross Recent Developments
Table 61. Kedrion Company Information
Table 62. Kedrion Business Overview
Table 63. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 64. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 65. Kedrion Recent Developments
Table 66. BPL Company Information
Table 67. BPL Business Overview
Table 68. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 69. BPL Human Coagulation Factor VIII Product Portfolio
Table 70. BPL Recent Developments
Table 71. Hualan Bio Company Information
Table 72. Hualan Bio Business Overview
Table 73. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 74. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 75. Hualan Bio Recent Developments
Table 76. RAAS Company Information
Table 77. RAAS Business Overview
Table 78. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 79. RAAS Human Coagulation Factor VIII Product Portfolio
Table 80. RAAS Recent Developments
Table 81. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Human Coagulation Factor VIII Sales by Region (2018-2023) & (K Bottles)
Table 83. Global Human Coagulation Factor VIII Sales Market Share by Region (2018-2023)
Table 84. Global Human Coagulation Factor VIII Sales by Region (2024-2029) & (K Bottles)
Table 85. Global Human Coagulation Factor VIII Sales Market Share by Region (2024-2029)
Table 86. Global Human Coagulation Factor VIII Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Human Coagulation Factor VIII Revenue Market Share by Region (2018-2023)
Table 88. Global Human Coagulation Factor VIII Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Human Coagulation Factor VIII Revenue Market Share by Region (2024-2029)
Table 90. North America Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 92. North America Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 93. North America Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 97. Europe Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 98. Europe Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 102. Asia Pacific Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 103. Asia Pacific Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 107. Latin America Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 108. Latin America Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 112. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 113. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Human Coagulation Factor VIII Sales by Type (2018-2023) & (K Bottles)
Table 116. Global Human Coagulation Factor VIII Sales by Type (2024-2029) & (K Bottles)
Table 117. Global Human Coagulation Factor VIII Sales Market Share by Type (2018-2023)
Table 118. Global Human Coagulation Factor VIII Sales Market Share by Type (2024-2029)
Table 119. Global Human Coagulation Factor VIII Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Human Coagulation Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Human Coagulation Factor VIII Revenue Market Share by Type (2018-2023)
Table 122. Global Human Coagulation Factor VIII Revenue Market Share by Type (2024-2029)
Table 123. Global Human Coagulation Factor VIII Price by Type (2018-2023) & (USD/Bottle)
Table 124. Global Human Coagulation Factor VIII Price by Type (2024-2029) & (USD/Bottle)
Table 125. Global Human Coagulation Factor VIII Sales by Application (2018-2023) & (K Bottles)
Table 126. Global Human Coagulation Factor VIII Sales by Application (2024-2029) & (K Bottles)
Table 127. Global Human Coagulation Factor VIII Sales Market Share by Application (2018-2023)
Table 128. Global Human Coagulation Factor VIII Sales Market Share by Application (2024-2029)
Table 129. Global Human Coagulation Factor VIII Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Human Coagulation Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Human Coagulation Factor VIII Revenue Market Share by Application (2018-2023)
Table 132. Global Human Coagulation Factor VIII Revenue Market Share by Application (2024-2029)
Table 133. Global Human Coagulation Factor VIII Price by Application (2018-2023) & (USD/Bottle)
Table 134. Global Human Coagulation Factor VIII Price by Application (2024-2029) & (USD/Bottle)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Human Coagulation Factor VIII Distributors List
Table 138. Human Coagulation Factor VIII Customers List
Table 139. Human Coagulation Factor VIII Industry Trends
Table 140. Human Coagulation Factor VIII Industry Drivers
Table 141. Human Coagulation Factor VIII Industry Restraints
Table 142. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Human Coagulation Factor VIII Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Human Coagulation Factor VIII Sales (K Bottles) of Manufacturers (2018-2023)
Table 7. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Human Coagulation Factor VIII Revenue of Manufacturers (2018-2023)
Table 9. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Human Coagulation Factor VIII Average Price (USD/Bottle) of Manufacturers (2018-2023)
Table 11. Global Human Coagulation Factor VIII Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Human Coagulation Factor VIII, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Shire (Baxter) Company Information
Table 17. Shire (Baxter) Business Overview
Table 18. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 19. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 20. Shire (Baxter) Recent Developments
Table 21. Bayer Company Information
Table 22. Bayer Business Overview
Table 23. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 24. Bayer Human Coagulation Factor VIII Product Portfolio
Table 25. Bayer Recent Developments
Table 26. CSL Company Information
Table 27. CSL Business Overview
Table 28. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 29. CSL Human Coagulation Factor VIII Product Portfolio
Table 30. CSL Recent Developments
Table 31. Pfizer Company Information
Table 32. Pfizer Business Overview
Table 33. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 34. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 35. Pfizer Recent Developments
Table 36. Grifols Company Information
Table 37. Grifols Business Overview
Table 38. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 39. Grifols Human Coagulation Factor VIII Product Portfolio
Table 40. Grifols Recent Developments
Table 41. Biogen Company Information
Table 42. Biogen Business Overview
Table 43. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 44. Biogen Human Coagulation Factor VIII Product Portfolio
Table 45. Biogen Recent Developments
Table 46. Octapharma Company Information
Table 47. Octapharma Business Overview
Table 48. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 49. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 50. Octapharma Recent Developments
Table 51. NovoNordisk Company Information
Table 52. NovoNordisk Business Overview
Table 53. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 54. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 55. NovoNordisk Recent Developments
Table 56. Greencross Company Information
Table 57. Greencross Business Overview
Table 58. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 59. Greencross Human Coagulation Factor VIII Product Portfolio
Table 60. Greencross Recent Developments
Table 61. Kedrion Company Information
Table 62. Kedrion Business Overview
Table 63. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 64. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 65. Kedrion Recent Developments
Table 66. BPL Company Information
Table 67. BPL Business Overview
Table 68. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 69. BPL Human Coagulation Factor VIII Product Portfolio
Table 70. BPL Recent Developments
Table 71. Hualan Bio Company Information
Table 72. Hualan Bio Business Overview
Table 73. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 74. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 75. Hualan Bio Recent Developments
Table 76. RAAS Company Information
Table 77. RAAS Business Overview
Table 78. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
Table 79. RAAS Human Coagulation Factor VIII Product Portfolio
Table 80. RAAS Recent Developments
Table 81. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Human Coagulation Factor VIII Sales by Region (2018-2023) & (K Bottles)
Table 83. Global Human Coagulation Factor VIII Sales Market Share by Region (2018-2023)
Table 84. Global Human Coagulation Factor VIII Sales by Region (2024-2029) & (K Bottles)
Table 85. Global Human Coagulation Factor VIII Sales Market Share by Region (2024-2029)
Table 86. Global Human Coagulation Factor VIII Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Human Coagulation Factor VIII Revenue Market Share by Region (2018-2023)
Table 88. Global Human Coagulation Factor VIII Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Human Coagulation Factor VIII Revenue Market Share by Region (2024-2029)
Table 90. North America Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 92. North America Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 93. North America Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 97. Europe Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 98. Europe Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 102. Asia Pacific Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 103. Asia Pacific Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 107. Latin America Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 108. Latin America Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Human Coagulation Factor VIII Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2018-2023) & (K Bottles)
Table 112. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2024-2029) & (K Bottles)
Table 113. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Human Coagulation Factor VIII Sales by Type (2018-2023) & (K Bottles)
Table 116. Global Human Coagulation Factor VIII Sales by Type (2024-2029) & (K Bottles)
Table 117. Global Human Coagulation Factor VIII Sales Market Share by Type (2018-2023)
Table 118. Global Human Coagulation Factor VIII Sales Market Share by Type (2024-2029)
Table 119. Global Human Coagulation Factor VIII Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Human Coagulation Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Human Coagulation Factor VIII Revenue Market Share by Type (2018-2023)
Table 122. Global Human Coagulation Factor VIII Revenue Market Share by Type (2024-2029)
Table 123. Global Human Coagulation Factor VIII Price by Type (2018-2023) & (USD/Bottle)
Table 124. Global Human Coagulation Factor VIII Price by Type (2024-2029) & (USD/Bottle)
Table 125. Global Human Coagulation Factor VIII Sales by Application (2018-2023) & (K Bottles)
Table 126. Global Human Coagulation Factor VIII Sales by Application (2024-2029) & (K Bottles)
Table 127. Global Human Coagulation Factor VIII Sales Market Share by Application (2018-2023)
Table 128. Global Human Coagulation Factor VIII Sales Market Share by Application (2024-2029)
Table 129. Global Human Coagulation Factor VIII Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Human Coagulation Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Human Coagulation Factor VIII Revenue Market Share by Application (2018-2023)
Table 132. Global Human Coagulation Factor VIII Revenue Market Share by Application (2024-2029)
Table 133. Global Human Coagulation Factor VIII Price by Application (2018-2023) & (USD/Bottle)
Table 134. Global Human Coagulation Factor VIII Price by Application (2024-2029) & (USD/Bottle)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Human Coagulation Factor VIII Distributors List
Table 138. Human Coagulation Factor VIII Customers List
Table 139. Human Coagulation Factor VIII Industry Trends
Table 140. Human Coagulation Factor VIII Industry Drivers
Table 141. Human Coagulation Factor VIII Industry Restraints
Table 142. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human Coagulation Factor VIIIProduct Picture
Figure 5. Global Human Coagulation Factor VIII Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Human Coagulation Factor VIII Market Size (2018-2029) & (US$ Million)
Figure 7. Global Human Coagulation Factor VIII Sales (2018-2029) & (K Bottles)
Figure 8. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2018-2029)
Figure 9. Recombinant Factor VIII Product Picture
Figure 10. Plasma-derived Factor VIII Product Picture
Figure 11. Hemophilia A Product Picture
Figure 12. Spontanous / Trauma Product Picture
Figure 13. Surgical Product Picture
Figure 14. Other Product Picture
Figure 15. Global Human Coagulation Factor VIII Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Human Coagulation Factor VIII Sales by Region in 2022
Figure 22. Global Human Coagulation Factor VIII Revenue by Region in 2022
Figure 23. North America Human Coagulation Factor VIII Market Size by Country in 2022
Figure 24. North America Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 25. North America Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Human Coagulation Factor VIII Market Size by Country in 2022
Figure 29. Europe Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 30. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 31. Germany Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Human Coagulation Factor VIII Market Size by Country in 2022
Figure 37. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 39. China Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Human Coagulation Factor VIII Market Size by Country in 2022
Figure 49. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 50. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Human Coagulation Factor VIII Market Size by Country in 2022
Figure 55. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 56. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Human Coagulation Factor VIII Sales Market Share by Type (2018-2029)
Figure 61. Global Human Coagulation Factor VIII Revenue Market Share by Type (2018-2029)
Figure 62. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2018-2029)
Figure 63. Global Human Coagulation Factor VIII Sales Market Share by Application (2018-2029)
Figure 64. Global Human Coagulation Factor VIII Revenue Market Share by Application (2018-2029)
Figure 65. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2018-2029)
Figure 66. Human Coagulation Factor VIII Value Chain
Figure 67. Human Coagulation Factor VIII Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Human Coagulation Factor VIII Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Human Coagulation Factor VIIIProduct Picture
Figure 5. Global Human Coagulation Factor VIII Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Human Coagulation Factor VIII Market Size (2018-2029) & (US$ Million)
Figure 7. Global Human Coagulation Factor VIII Sales (2018-2029) & (K Bottles)
Figure 8. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2018-2029)
Figure 9. Recombinant Factor VIII Product Picture
Figure 10. Plasma-derived Factor VIII Product Picture
Figure 11. Hemophilia A Product Picture
Figure 12. Spontanous / Trauma Product Picture
Figure 13. Surgical Product Picture
Figure 14. Other Product Picture
Figure 15. Global Human Coagulation Factor VIII Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Human Coagulation Factor VIII Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Human Coagulation Factor VIII Sales by Region in 2022
Figure 22. Global Human Coagulation Factor VIII Revenue by Region in 2022
Figure 23. North America Human Coagulation Factor VIII Market Size by Country in 2022
Figure 24. North America Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 25. North America Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Human Coagulation Factor VIII Market Size by Country in 2022
Figure 29. Europe Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 30. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 31. Germany Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Human Coagulation Factor VIII Market Size by Country in 2022
Figure 37. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 39. China Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Human Coagulation Factor VIII Market Size by Country in 2022
Figure 49. Latin America Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 50. Latin America Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Human Coagulation Factor VIII Market Size by Country in 2022
Figure 55. Middle East and Africa Human Coagulation Factor VIII Sales Market Share by Country (2018-2029)
Figure 56. Middle East and Africa Human Coagulation Factor VIII Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Human Coagulation Factor VIII Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Human Coagulation Factor VIII Sales Market Share by Type (2018-2029)
Figure 61. Global Human Coagulation Factor VIII Revenue Market Share by Type (2018-2029)
Figure 62. Global Human Coagulation Factor VIII Price (USD/Bottle) by Type (2018-2029)
Figure 63. Global Human Coagulation Factor VIII Sales Market Share by Application (2018-2029)
Figure 64. Global Human Coagulation Factor VIII Revenue Market Share by Application (2018-2029)
Figure 65. Global Human Coagulation Factor VIII Price (USD/Bottle) by Application (2018-2029)
Figure 66. Human Coagulation Factor VIII Value Chain
Figure 67. Human Coagulation Factor VIII Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Human Coagulation Factor VIII Industry Opportunities and Challenges
